Shradha Bisht

Employment

• Uttarancahl Institute of Pharmaceutical Sciences, Uttaranchal University
  2025 - Present
• College of Pharmacy, Shivalik Campus Professor
  2024 - 2025
• Amity University Associate PRofessor
  2022 - 2024
• Babu Banarasi Das Northern India Institute of Technology Associate Professor
  2020 - 2022
• Sardar Bhagwan Singh University Associate Professor
  2018 - 2020
• Sardar Bhagwan Singh Post Graduate Institute of Biomedical Science and Research Associate Professor
  2016 - 2018
• SBS PG Institute of Biomedical Sciences and Research, Balawala Asst. Professor
  2011 - 2016
• Suresh Gyan Vihar University Assistant Professor
  2009 - 2011
• Kota College of Pharmacy Assistant Professor
  2006 - 2009

Education

• RUHS Ph.D
  2008 - 2013
• The Maharaja Sayajirao University of Baroda M.Pharm
  2004 - 2006
• Hemwati Nandan Bahuguna Garhwal University B.Pharm
  1997 - 2002

Projects & Funding

Projects & funding information is unavailable.

Publications (36)

• Blood–Brain Barrier in Brain Health, Aging, and Neurodegenerative Diseases
  2026 DOI: 10.1201/9781003530510-2
  +Save
• Exploring the therapeutic potential of Coffea arabica : pharmacological evaluation of extracts, fractions, and isolated compounds to treat diabetes and to treat diabetes-associated hepatic dysfunction and dyslipidemia in rats
  Natural Product Research 2026 DOI: 10.1080/14786419.2024.2437026
  +Save
• Quality Challenge in Regulatory Approval of Medicinal Products Containing Combinations of Herbal Substances
  Formulating Pharma Nutra and Cosmeceutical Products from Herbal Substances Dosage Forms and Delivery Systems 2025 DOI: 10.1002/9781119769484.ch23
  +Save
• Nanotherapeutics in tuberculosis: Pulmonary and extrapulmonary applications
  Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases 2025 DOI: 10.1016/B978-0-443-28836-4.00011-1
  +Save
• Nanotherapeutics in metabolic diseases-Associated infections
  Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases 2025 DOI: 10.1016/B978-0-443-28836-4.00026-3
  +Save
• In Silico and Experimental Evaluation of Myricetin in Insulin Resistance-Associated PCOS in Rats
  Chemistry and Biodiversity 2025 DOI: 10.1002/cbdv.202502165
  +Save
• Diabetic cardiomyopathy and COVID-19: intersecting pathways and amplified cardiovascular risk
  Frontiers in Pharmacology 2025 DOI: 10.3389/fphar.2025.1683159
  +Save
• Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer’s disease in type 2 diabetes
  Metabolic Brain Disease 2025 DOI: 10.1007/s11011-025-01555-4
  +Save
• Association between sleep disturbance and metabolic dysfunctions in adipose tissue: Insights into melatonin's role
  Biochemical and Biophysical Research Communications 2025 DOI: 10.1016/j.bbrc.2025.151978
  +Save
• ADVANCES IN COCRYSTALS OF ANTICANCER AGENTS: FORMULATION STRATEGIES AND THERAPEUTIC IMPLICATIONS
  International Journal of Pharmacy and Pharmaceutical Sciences 2024 DOI: 10.22159/ijpps.2024v16i6.51044
  +Save